Biochemistry and Cell Biology · 2018 · 55 citations · 24 references
MedicineCell BiologyNephrologyAutophagyCell TherapyRegenerative MedicineDiabetes MellitusDiabetic Kidney DiseaseDiabetic NephropathyMesenchymal Stem Cell TherapyMesenchymal Stromal Cell TherapyRenal DiseaseKidney PathologyKidney PhysiologyKidney Tissue ModelsMelatonin ImmunomodulationMelatonin SupplementationMelatonin TreatmentSuperoxide Dismutase 1Superoxide Dismutase Function
The aim of this study was to investigate the effect of a regenerative therapy comprising mesenchymal stem cells (MSCs) pretreated with melatonin (MT) as a new therapy for underlying diabetic nephropathy (DN) pathogenesis in a rat model, and its possible effect on autophagy protein Beclin-1. Forty adult male albino Wistar rats were distributed among 4 groups: (i) control, (ii) DN, (iii) MSC-treated, and (iv) treated with MSCs that were pre-incubated in-vitro with MT (5 μmol·L –1 for 24 h; MSCs + MT). MSCs treatment significantly improved the renal functions and ameliorated the measured underlying DN pathogenesis and elevation of Beclin-1 protein levels compared with the DN group. In-vitro pretreatment of MSCs with MT enhanced proliferation and efficiency, and thus improved the kidney functions by increasing superoxide dismutase (SOD-1) and Beclin-1, and decreasing transforming growth factor (TGF-β) markers in the kidney tissue, compared with the MSC group (P < 0.05). In conclusion: MSCs represent a promising target in DN management, and their effect can be intensified by pretreatment with MT. The elevated levels of Beclin-1 could be a mediator.
24
Fernando Ezquer, Marcelo Ezquer, Daniela B. Parrau et al. · Biology of Blood and Marrow Transplantation · 2008 · 354 citations · Full text